• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec18
WuXi Biologics Shareholders Reduce Holdings, Stake Drops to 16.97%
09:47
WuXi Lux Holding Subsidiary Acquires Fund Investment and Transfers Shares
09:23
Dec17
JPMorgan Increases Its Stake in WuXi Biologics by 872,123 Shares
11:20
Dec15
WuXi AppTec Completes Sale of Kendrion and ZS Medicine Shares to Hillhouse
14:27
Dec10
QIA Sells 869,400 Shares of WuXi Biologics
11:16
Nov28
Nomura Reiterates Buy Rating on WuXi AppTec, Raises Target Price to HKD132.8
03:55

Schedules & Filings

Schedules
Filings
Oct26
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 12.04 B, Net Income 3.515 B, EPS 1.2083

Sep26
Distribution Plan(CST)

Cash dividend 0.35 CNY

Distribution Plan(CST)

Cash dividend 0.35 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More